Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,339 shares at $420.24 ($1.4M) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Scheduled sale ($1.4M) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $422.74 | 591 | $250K | 17.8% |
| 2 | $420.24 | 1,374 | $577K | 41.1% |
| 3 | $420.24 | 1,374 | $577K | 41.1% |
| Total | $420.68 avg | 3,339 | $1.4M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |